Parallel Advisors’s Zymeworks ZYME Stock Holding History

Parallel Advisors’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.6K	Sell	329 -23	-7%	-$584	﹤0.01%	2996
2026 Q1	$8.81K	Buy	352 +23	+7%	+$544	﹤0.01%	2811
2025 Q4	$8.66K	Hold	329	–	–	﹤0.01%	2663
2025 Q3	$5.62K	Hold	329	–	–	﹤0.01%	2736
2025 Q2	$4.13K	Hold	329	–	–	﹤0.01%	2806
2025 Q1	$3.92K	Hold	329	–	–	﹤0.01%	2763
2024 Q4	$4.82K	Hold	329	–	–	﹤0.01%	2660
2024 Q3	$4.13K	Hold	329	–	–	﹤0.01%	2677
2024 Q2	$2.8K	Hold	329	–	–	﹤0.01%	2699
2024 Q1	$3.46K	Hold	329	–	–	﹤0.01%	2643
2023 Q4	$3.42K	Buy	329 +13	+4%	+$104	﹤0.01%	2636
2023 Q3	$2K	Buy	+316	New	+$2.33K	﹤0.01%	2817

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Parallel Advisors's ZYME Position: Q2 2026 in Review

Parallel Advisors reduced its Zymeworks (ZYME) stake by 6.5% in Q2 2026, selling an estimated $584 and leaving 329 shares worth $8.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2996.

Parallel Advisors first reported a position in ZYME in Q3 2023 and has held it in 12 quarters since. The position peaked at $8.81K in Q1 2026. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

Parallel Advisors held 329 shares of Zymeworks worth $8.6K as of Q2 2026.
Parallel Advisors sold 23 Zymeworks shares in Q2 2026, an estimated $584.
Zymeworks made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2996 holding.
Parallel Advisors first reported a position in Zymeworks in Q3 2023 and has held it in 12 quarters since.
Parallel Advisors's Zymeworks position peaked at $8.81K in Q1 2026.
202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.